CanSino Biologics Inc (CJH) — Strategic Asset Allocation Index
CanSino Biologics Inc (CJH) has a Strategic Asset Allocation Index of 47.8% as of June 2023. Strategic assets (PP&E of €2.85 Billion plus long-term investments of €-) total €2.85 Billion, measured against net assets of €5.97 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of CanSino Biologics Inc to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
CanSino Biologics Inc Strategic Asset Allocation Index (2016–2022)
This chart shows how CanSino Biologics Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 47.8%, representing strategic assets of €2.85 Billion against net assets of €5.97 Billion EUR. See CJH financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for CanSino Biologics Inc (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for CanSino Biologics Inc from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see CanSino Biologics Inc (CJH) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 42.4% | €3.07 Billion | €3.07 Billion | €- | €7.25 Billion | ▲ +16.4 pp |
| 2021 | 26.0% | €2.22 Billion | €2.22 Billion | €- | €8.55 Billion | ▲ +11.6 pp |
| 2020 | 14.4% | €873.95 Million | €873.95 Million | €- | €6.07 Billion | ▼ -24.7 pp |
| 2019 | 39.1% | €574.89 Million | €574.89 Million | €- | €1.47 Billion | ▼ -61.9 pp |
| 2018 | 101.0% | €507.45 Million | €507.45 Million | €- | €502.32 Million | ▲ +35.7 pp |
| 2017 | 65.4% | €396.89 Million | €396.89 Million | €- | €607.33 Million | ▼ -8.4 pp |
| 2016 | 73.8% | €158.18 Million | €158.18 Million | €- | €214.47 Million | — |